Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer.
Iwasa T, Tsurutani J, Watanabe S, Kato R, Mizuno Y, Kojima Y, Takashima T, Matsunami N, Morimoto T, Yamamura J, Ohtani S, Tanabe Y, Yoshinami T, Takano T, Komoike Y, Nakagawa K.
Iwasa T, et al. Among authors: mizuno y.
BMC Cancer. 2019 Oct 16;19(1):962. doi: 10.1186/s12885-019-6200-5.
BMC Cancer. 2019.
PMID: 31619197
Free PMC article.
Clinical Trial.